Nautilus Biotechnology, Inc. financial data

Symbol
NAUT on Nasdaq
Location
2701 Eastlake Ave East, Seattle, WA
Fiscal year end
December 31
Former names
ARYA Sciences Acquisition Corp III (to 6/8/2021)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.85K % -10.6%
Debt-to-equity 16 % +10.6%
Return On Equity -30.9 % -37.7%
Return On Assets -26.6 % -35.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 126M shares +0.71%
Common Stock, Shares, Outstanding 126M shares +0.83%
Entity Public Float 113M USD -48.4%
Common Stock, Value, Issued 13K USD 0%
Weighted Average Number of Shares Outstanding, Basic 125M shares +0.41%
Weighted Average Number of Shares Outstanding, Diluted 125M shares +0.41%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 50.5M USD +6.83%
General and Administrative Expense 31M USD +7.26%
Nonoperating Income (Expense) 10.7M USD -14.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -70.8M USD -11.2%
Earnings Per Share, Basic -0.56 USD/shares -9.8%
Earnings Per Share, Diluted -0.56 USD/shares -9.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 27.6M USD +42.5%
Cash, Cash Equivalents, and Short-term Investments 130M USD -25.1%
Assets, Current 133M USD -24.9%
Property, Plant and Equipment, Net 4.08M USD -4.48%
Operating Lease, Right-of-Use Asset 28.3M USD -13.4%
Other Assets, Noncurrent 1.18M USD 0%
Assets 243M USD -20.6%
Accounts Payable, Current 987K USD -39.8%
Employee-related Liabilities, Current 1.34M USD -48.1%
Liabilities, Current 7.63M USD -16.3%
Operating Lease, Liability, Noncurrent 26.4M USD -15.1%
Liabilities 34M USD -15.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 57K USD
Retained Earnings (Accumulated Deficit) -273M USD -35%
Stockholders' Equity Attributable to Parent 209M USD -21.3%
Liabilities and Equity 243M USD -20.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.3M USD -29.9%
Net Cash Provided by (Used in) Financing Activities 245K USD
Net Cash Provided by (Used in) Investing Activities 22.4M USD
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 126M shares +0.83%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.33M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28.6M USD +40.4%
Deferred Tax Assets, Valuation Allowance 78.4M USD +34.6%
Deferred Tax Assets, Gross 85.9M USD +28.5%
Operating Lease, Liability 30.5M USD -12%
Depreciation 1.98M USD +6.81%
Payments to Acquire Property, Plant, and Equipment 647K USD -6.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -70.5M USD -13.5%
Lessee, Operating Lease, Liability, to be Paid 39.4M USD -15.1%
Property, Plant and Equipment, Gross 10.6M USD +19.2%
Operating Lease, Liability, Current 4.1M USD +15.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.87M USD -4.34%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.59M USD +2.71%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.9M USD -24.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.89M USD +0.16%
Deferred Tax Assets, Operating Loss Carryforwards 32.7M USD +51.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 3.15M USD +33%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.82M USD -15.6%
Operating Lease, Payments 1.7M USD +41.7%
Additional Paid in Capital 482M USD +2.96%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 7.56M USD -12.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%